Showing results (11-20 of 333) with videos related to

Sort By:
Pageof 34
Cytokine|October 22, 2013
Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in JapanChikako Kiyohara, Takahiko Horiuchi, Koichi Takayama, et al.
Cancer Medicine|November 17, 2022
Efficacy and safety of anamorelin in patients with cancer cachexia: Post-hoc subgroup analyses of a placebo-controlled studyKoichi Takayama, Toru Takiguchi, Naoyuki Komura, et al.
In Vivo (Athens, Greece)|October 30, 2025
Disproportionality Analysis of Gastrointestinal Adverse Events Associated With Trastuzumab Deruxtecan Using the Japanese Adverse Drug Event Report databaseYuko Kanbayashi, Risa Morioka, Koichi Takayama, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 20, 2005
NQO1, MPO, and the risk of lung cancer: a HuGE reviewChikako Kiyohara, Kouichi Yoshimasu, Koichi Takayama, et al.
Oncology|January 10, 2024
Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective AnalysisYuko Kanbayashi, Takeshi Ishikawa, Eigo Otsuji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2012
Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese populationChikako Kiyohara, Takahiko Horiuchi, Koichi Takayama, et al.
BMC Cancer|October 26, 2011
Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese populationChikako Kiyohara, Takahiko Horiuchi, Koichi Takayama, et al.
In Vivo (Athens, Greece)|February 26, 2025
Factors Contributing to Blood Glucose Elevation Associated With Olanzapine Used as an Antiemetic During Cancer ChemotherapyYuko Kanbayashi, Takeshi Ishikawa, Tetsuya Taguchi, et al.
Future Oncology (London, England)|November 29, 2007
Lung cancer susceptibility: are we on our way to identifying a high-risk group?Chikako Kiyohara, Kouichi Yoshimasu, Koichi Takayama, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 3, 2026
Disproportionality analysis of hematologic adverse events associated with trastuzumab deruxtecan using the Japanese pharmacovigilance databaseYuko Kanbayashi, Risa Morioka, Koichi Takayama, et al.
Pageof 34